...
机译:“二代”1,2,3-三唑基的卟啉基牙龈抑制剂粘附着口服链球菌和生物膜形成
Department of Chemistry University of Louisville 2320 South Brook Street Louisville Kentucky 40292 USA;
Department of Oral Immunology and Infectious Diseases University of Louisville School of Dentistry 501 S. Preston St. Louisville Kentucky 40292 USA.;
Department of Oral Immunology and Infectious Diseases University of Louisville School of Dentistry 501 S. Preston St. Louisville Kentucky 40292 USA.;
Department of Chemistry University of Louisville 2320 South Brook Street Louisville Kentucky 40292 USA;
‘Second-generation' 1; 2; 3-triazole-based inhibitors; Porphyromonas gingivalis; adherence to oral streptococci and biofilm formation;
机译:“二代”1,2,3-三唑基的卟啉基牙龈抑制剂粘附着口服链球菌和生物膜形成
机译:类似于YadA的自转运蛋白,非典型的Veillonella中的Hag1是多价血凝素,参与粘附于口腔链球菌,牙龈卟啉单胞菌和人类口腔颊细胞
机译:离散的蛋白质决定因素指导牙龈卟啉单胞菌对口腔链球菌的种属特异性粘附。
机译:作为COX-2选择性抑制剂的制备新的L-(4-磺基苯基)-5-芳基-1,2,3-三唑5-14℃衍生物
机译:合成评价β-糖基-1,2,3-三唑衍生物作为β-糖苷酶抑制剂。
机译:牙龈卟啉单胞菌的第二代 123-三唑基抑制剂对口腔链球菌的粘附和生物膜的形成
机译:基于第二代'1,2,3-三唑基的卟啉毒素牙龈粘附到口服链球菌和生物膜形成